Description
Bdparib 300mg Tablet is a targeted therapy medication. Its active ingredient is a PARP inhibitor, specifically designed to interfere with the repair of damaged DNA within cancer cells. Cancer cells, particularly those with certain genetic mutations like BRCA, are more reliant on PARP for DNA repair than normal cells. By inhibiting PARP, Bdparib prevents these cancer cells from repairing their DNA, leading to cell death. This mechanism is particularly effective in treating certain types of ovarian, fallopian tube, and primary peritoneal cancers, especially in patients who have responded to previous platinum-based chemotherapy. The typical dosage is 300mg twice daily, but should always be taken as prescribed by a healthcare professional. Common side effects may include nausea, fatigue, vomiting, headache, and diarrhea. It is important to store Bdparib 300mg Tablets at room temperature, away from moisture and heat, and out of reach of children.
